STERIS plc (NYSE:STE) Shares Acquired by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lifted its holdings in shares of STERIS plc (NYSE:STE) by 84.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,174 shares of the medical equipment provider’s stock after buying an additional 1,452 shares during the quarter. Dana Investment Advisors Inc.’s holdings in STERIS were worth $652,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Ashton Thomas Securities LLC acquired a new position in shares of STERIS during the 3rd quarter worth approximately $25,000. Human Investing LLC acquired a new position in shares of STERIS during the 4th quarter worth approximately $31,000. Anfield Capital Management LLC raised its stake in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the period. Central Pacific Bank Trust Division raised its stake in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares during the period. Finally, Manchester Capital Management LLC raised its stake in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 137 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Up 0.3 %

NYSE STE opened at $233.02 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The business has a fifty day moving average price of $216.96 and a 200 day moving average price of $222.78. The company has a market cap of $22.89 billion, a P/E ratio of 49.47 and a beta of 0.92. STERIS plc has a one year low of $197.82 and a one year high of $248.24.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s payout ratio is currently 48.41%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on STE. Stephens reissued an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler increased their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.